144 related articles for article (PubMed ID: 8626570)
1. NK-lysin, a disulfide-containing effector peptide of T-lymphocytes, is reduced and inactivated by human thioredoxin reductase. Implication for a protective mechanism against NK-lysin cytotoxicity.
Andersson M; Holmgren A; Spyrou G
J Biol Chem; 1996 Apr; 271(17):10116-20. PubMed ID: 8626570
[TBL] [Abstract][Full Text] [Related]
2. Protein disulfide-isomerase is a substrate for thioredoxin reductase and has thioredoxin-like activity.
Lundström J; Holmgren A
J Biol Chem; 1990 Jun; 265(16):9114-20. PubMed ID: 2188973
[TBL] [Abstract][Full Text] [Related]
3. NK-lysin, a novel effector peptide of cytotoxic T and NK cells. Structure and cDNA cloning of the porcine form, induction by interleukin 2, antibacterial and antitumour activity.
Andersson M; Gunne H; Agerberth B; Boman A; Bergman T; Sillard R; Jörnvall H; Mutt V; Olsson B; Wigzell H
EMBO J; 1995 Apr; 14(8):1615-25. PubMed ID: 7737114
[TBL] [Abstract][Full Text] [Related]
4. Interaction of NK lysin, a peptide produced by cytolytic lymphocytes, with endotoxin.
Andersson M; Girard R; Cazenave P
Infect Immun; 1999 Jan; 67(1):201-5. PubMed ID: 9864216
[TBL] [Abstract][Full Text] [Related]
5. Selenite is a substrate for calf thymus thioredoxin reductase and thioredoxin and elicits a large non-stoichiometric oxidation of NADPH in the presence of oxygen.
Kumar S; Björnstedt M; Holmgren A
Eur J Biochem; 1992 Jul; 207(2):435-39. PubMed ID: 1321713
[TBL] [Abstract][Full Text] [Related]
6. Selenodiglutathione is a highly efficient oxidant of reduced thioredoxin and a substrate for mammalian thioredoxin reductase.
Björnstedt M; Kumar S; Holmgren A
J Biol Chem; 1992 Apr; 267(12):8030-4. PubMed ID: 1569062
[TBL] [Abstract][Full Text] [Related]
7. Formation and properties of mixed disulfides between thioredoxin reductase from Escherichia coli and thioredoxin: evidence that cysteine-138 functions to initiate dithiol-disulfide interchange and to accept the reducing equivalent from reduced flavin.
Veine DM; Mulrooney SB; Wang PF; Williams CH
Protein Sci; 1998 Jun; 7(6):1441-50. PubMed ID: 9655349
[TBL] [Abstract][Full Text] [Related]
8. Enzymatic reduction of alloxan by thioredoxin and NADPH-thioredoxin reductase.
Holmgren A; Lyckeborg C
Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5149-52. PubMed ID: 6933551
[TBL] [Abstract][Full Text] [Related]
9. NK-lysin, structure and function of a novel effector molecule of porcine T and NK cells.
Andersson M; Gunne H; Agerberth B; Boman A; Bergman T; Olsson B; Dagerlind A; Wigzell H; Boman HG; Gudmundsson GH
Vet Immunol Immunopathol; 1996 Nov; 54(1-4):123-6. PubMed ID: 8988855
[TBL] [Abstract][Full Text] [Related]
10. Identification of an anti-mycobacterial domain in NK-lysin and granulysin.
Andreu D; Carreño C; Linde C; Boman HG; Andersson M
Biochem J; 1999 Dec; 344 Pt 3(Pt 3):845-9. PubMed ID: 10585872
[TBL] [Abstract][Full Text] [Related]
11. Mechanism and structure of thioredoxin reductase from Escherichia coli.
Williams CH
FASEB J; 1995 Oct; 9(13):1267-76. PubMed ID: 7557016
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of Escherichia coli thioredoxin reductase refined at 2 A resolution. Implications for a large conformational change during catalysis.
Waksman G; Krishna TS; Williams CH; Kuriyan J
J Mol Biol; 1994 Feb; 236(3):800-16. PubMed ID: 8114095
[TBL] [Abstract][Full Text] [Related]
13. Interaction of amoebapores and NK-lysin with symmetric phospholipid and asymmetric lipopolysaccharide/phospholipid bilayers.
Gutsmann T; Riekens B; Bruhn H; Wiese A; Seydel U; Leippe M
Biochemistry; 2003 Aug; 42(32):9804-12. PubMed ID: 12911324
[TBL] [Abstract][Full Text] [Related]
14. NADPH and oxidized thioredoxin mediate redox interconversion of calf-liver and Escherichia coli thioredoxin reductase.
Martínez-Galisteo E; García-Alfonso C; Alicia Padilla C; Antonio Bárcena J; López-Barea J
Mol Cell Biochem; 1992 Jan; 109(1):61-9. PubMed ID: 1319549
[TBL] [Abstract][Full Text] [Related]
15. Bacteriocin AS-48, a microbial cyclic polypeptide structurally and functionally related to mammalian NK-lysin.
González C; Langdon GM; Bruix M; Gálvez A; Valdivia E; Maqueda M; Rico M
Proc Natl Acad Sci U S A; 2000 Oct; 97(21):11221-6. PubMed ID: 11005847
[TBL] [Abstract][Full Text] [Related]
16. Conserved structure and function in the granulysin and NK-lysin peptide family.
Linde CM; Grundström S; Nordling E; Refai E; Brennan PJ; Andersson M
Infect Immun; 2005 Oct; 73(10):6332-9. PubMed ID: 16177304
[TBL] [Abstract][Full Text] [Related]
17. Motexafin gadolinium, a tumor-selective drug targeting thioredoxin reductase and ribonucleotide reductase.
Hashemy SI; Ungerstedt JS; Zahedi Avval F; Holmgren A
J Biol Chem; 2006 Apr; 281(16):10691-7. PubMed ID: 16481328
[TBL] [Abstract][Full Text] [Related]
18. A NK-lysin from Cynoglossus semilaevis enhances antimicrobial defense against bacterial and viral pathogens.
Zhang M; Long H; Sun L
Dev Comp Immunol; 2013; 40(3-4):258-65. PubMed ID: 23524198
[TBL] [Abstract][Full Text] [Related]
19. Human IgG is substrate for the thioredoxin system: differential cleavage pattern of interchain disulfide bridges in IgG subclasses.
Magnusson CG; Björnstedt M; Holmgren A
Mol Immunol; 1997 Jul; 34(10):709-17. PubMed ID: 9430198
[TBL] [Abstract][Full Text] [Related]
20. An amphipathic helical motif common to tumourolytic polypeptide NK-lysin and pulmonary surfactant polypeptide SP-B.
Andersson M; Curstedt T; Jörnvall H; Johansson J
FEBS Lett; 1995 Apr; 362(3):328-32. PubMed ID: 7729523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]